Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by Duediligence33on Sep 02, 2018 2:19pm
303 Views
Post# 28554548

RE:Faircourt Asset Management on Midas Letter

RE:Faircourt Asset Management on Midas LetterExcellent assessment of Aphria by a professional investor. Listen to him not uneducated posters. He has hit on all the buzz points that will see APH hit new highs very soon. The 2 to 1 last 3 yr traditional ratio of Canopy/Aphria share price will be restored. When Weed hits $ 100 we will be $ 50. Should be $ 30 very soon to match their $ 60 and that of Tilray.
Bullboard Posts